Photoimmunotherapy – novel type of cancer immunotherapy
- This topic has 0 replies, 1 voice, and was last updated 7 years, 5 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
that uses infrared light to activate rapid and selective killing of cancer cells, also called near-infrared photoimmunotherapy (NIR-PIT)
An early-phase clinical trial of NIR-PIT is already underway in people with recurrent head and neck cancers, which overexpress the epidermal growth factor receptor EGFR1.
Near-infrared photoimmunotherapy uses an antibody–photoabsorber conjugate that binds to cancer cells. When near-infrared light is applied, the cells swell and then burst, causing the cancer cell to die. Photoimmunotherapy is in clinical trials in patients with inoperable tumors.
This link explains more and allows you to watch a short video:
https://www.cancer.gov/news-events/cancer-currents-blog/2016/photoimmunotherapy-cancerHugs
Marion
Viewing 1 post (of 1 total)
- The forum ‘Radiation Treatments & Options’ is closed to new topics and replies.